A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 26, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-K for FY2026, filed Sep 9, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the LSAK SEC filings page.
Lesaka Technologies, Inc. (LSAK) reported $721.6M in revenue for fiscal year 2026, up 9.4% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
FY2026 shows a return to profitability, but growth still requires heavier overhead and a more leveraged balance sheet.
Operating cash flow reached$52.4M against net income of$2.8M , making reported cash generation far larger than accounting profit. With depreciation and amortization at$47.3M and free cash flow at$31.8M , the conversion is materially influenced by non-cash expense while still leaving cash after investment.
Revenue grew
Liabilities grew
Financial Health Signals
Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Lesaka Technologies, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Lesaka Technologies, Inc. has an operating margin of 1.8%, meaning the company retains $2 of operating profit per $100 of revenue. Among its peers this margin ranks in the lower range, for a profitability score of 29/100. This is up from -4.2% the prior year.
Lesaka Technologies, Inc.'s revenue grew 9.4% year-over-year to $721.6M, a solid pace of expansion. This earns a growth score of 72/100.
Lesaka Technologies, Inc. has a moderate D/E ratio of 0.95. This balance of debt and equity financing earns a leverage score of 32/100.
Lesaka Technologies, Inc.'s current ratio of 1.59 indicates adequate short-term liquidity, earning a score of 45/100. The company can meet its near-term obligations, though with limited headroom.
Lesaka Technologies, Inc. has a free cash flow margin of 4.4%, earning a moderate score of 32/100. The company generates positive cash flow after capital investments, but with room for improvement.
Lesaka Technologies, Inc. generates a 1.3% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 29/100. This is up from -57.1% the prior year.
Lesaka Technologies, Inc. scores 2.21, placing it in the grey zone between 1.81 and 2.99. The largest contribution to the score comes from revenue of $721.6M against total assets of $699.3M. This signals moderate financial risk that warrants monitoring.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Lesaka Technologies, Inc. passes 7 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) passes.
For every $1 of reported earnings, Lesaka Technologies, Inc. generates $19.02 in operating cash flow ($52.4M OCF vs $2.8M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Lesaka Technologies, Inc. earns $0.69 in operating income for every $1 of interest expense ($12.7M vs $18.5M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Lesaka Technologies, Inc. generated $188.3M in revenue in Q4 2026. This represents an increase of 11.8% from the same quarter a year earlier. Against the prior quarter it is up 2.9%.
Lesaka Technologies, Inc.'s EBITDA was $16.4M in Q4 2026, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is up 12.1%.
Lesaka Technologies, Inc. reported $2.9M in net income in Q4 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is up 417.8%.
Lesaka Technologies, Inc. earned $0.04 per diluted share (EPS) in Q4 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is up 300.0%.
Cash & Balance Sheet
Lesaka Technologies, Inc. generated $7.5M in free cash flow in Q4 2026, representing cash available after capex. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is down 78.0%.
Lesaka Technologies, Inc. held $81.4M in cash against $194.6M in long-term debt as of Q4 2026.
Not reported for Q4 2026.
Margins & Returns
Lesaka Technologies, Inc.'s operating margin was 3.2% in Q4 2026, reflecting core business profitability. This is up 20.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.0 percentage points.
Lesaka Technologies, Inc.'s net profit margin was 1.5% in Q4 2026, showing the share of revenue converted to profit. This is up 20.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.2 percentage points.
Lesaka Technologies, Inc.'s quarterly ROE was 1.4% in Q4 2026: one quarter's net income over shareholder equity, not annualized. This is up 21.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.1 percentage points.
Not reported for Q4 2026.
Capital Allocation
Lesaka Technologies, Inc. spent $28K on share buybacks in Q4 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 97.3% from the same quarter a year earlier. Against the prior quarter it is down 30.0%.
Lesaka Technologies, Inc. invested $9.3M in capex in Q4 2026, funding long-term assets and infrastructure. This represents an increase of 128.0% from the same quarter a year earlier. Against the prior quarter it is up 175.0%.
Not reported for Q4 2026.
LSAK Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $188.3M+11.8% | $183.1M+13.4% | $178.7M+1.4% | $171.4M+11.6% | $168.5M+15.4% | $161.4M+16.8% | $176.2M+22.5% | $153.6M+12.8% |
| Cost of Revenue | $125.8M+4.6% | $123.9M+5.8% | $122.7M-6.2% | $118.4M-0.4% | $120.2M+5.8% | $117.2M+8.6% | $130.9M+14.5% | $118.9M+10.6% |
| SG&A Expenses | $38.5M+25.9% | $39.2M+20.4% | $36.1M+6.6% | $39.6M+48.5% | $30.6M+53.9% | $32.6M+40.9% | $33.8M+57.3% | $26.7M+18.6% |
| Operating Income | $6.1Mn/m | $4.1M+1016.1% | $2.1M+293.1% | $383Kn/m | -$28.8Mn/m | $366K-53.9% | $547K-75.9% | -$45K-119.7% |
| EBITDA | $16.4Mn/m | $14.6M+66.3% | $15.7M+79.2% | $13.3M+113.1% | -$18.0M-418.5% | $8.8M+33.6% | $8.8M+8.5% | $6.2M+2.4% |
| Interest Expense | $4.5M-2.5% | $4.5M-23.7% | $4.6M-26.7% | $4.9M-2.7% | $4.7M-4.2% | $5.9M+28.1% | $6.3M+29.9% | $5.0M+2.5% |
| Income Tax | -$598Kn/m | $1.5Mn/m | $670Kn/m | -$146K-287.2% | -$6.7M-553.0% | -$2.9M-415.1% | -$6.4M-1034.7% | $78K-70.5% |
| Net Income | $2.9Mn/m | $552Kn/m | $3.6Mn/m | -$4.3Mn/m | -$31.6Mn/m | -$22.4Mn/m | -$32.5Mn/m | -$4.5Mn/m |
| EPS (Basic) | $0.04n/m | $0.01n/m | $0.04n/m | -$0.05n/m | -$0.33n/m | -$0.28n/m | -$0.40n/m | -$0.07n/m |
| EPS (Diluted) | $0.04n/m | $0.01n/m | $0.04n/m | -$0.05n/m | -$0.33n/m | -$0.28n/m | -$0.40n/m | -$0.07n/m |
| Diluted Shares (Avg) | N/A | 79M+1.4% | 80M+4.0% | 79,094+27.0% | N/A | 78M+28.5% | 77M+26.3% | 62,265+2.1% |
Not reported in any period shown, so not listed: Gross Profit, R&D Expenses.
LSAK Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $699.3M+7.3% | $675.0M+4.0% | $704.6M+10.0% | $652.9M+18.3% | $651.5M+16.7% | $649.2M+17.7% | $640.6M+10.3% | $551.9M+0.9% |
| Current Assets | $267.7M+9.8% | $274.5M+29.2% | $284.9M+34.8% | $240.5M+43.8% | $243.9M+30.0% | $212.4M+14.4% | $211.4M+4.3% | $167.3M-3.2% |
| Cash & Equivalents | $81.4M+6.4% | $90.6M+27.6% | $69.5M+14.6% | $72.2M+45.2% | $76.5M+29.6% | $71.0M+28.6% | $60.6M+36.8% | $49.7M-9.7% |
| Short-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Inventory | $20.1M-14.6% | $17.5M-7.1% | $25.1M-8.2% | $19.0M-6.1% | $23.6M+29.2% | $18.8M-13.5% | $27.3M-1.0% | $20.2M-27.2% |
| Accounts Receivable | N/A | $45.5M+25.9% | $58.2M+26.1% | $44.8M+50.2% | $42.5M+16.0% | $36.1M+5.2% | $46.2M+12.4% | $29.8M+6.8% |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Goodwill | $215.3M+8.0% | $207.1M-1.3% | $211.9M+5.5% | $205.0M+39.8% | $199.4M+43.9% | $209.8M+57.2% | $200.8M+45.8% | $146.6M+10.1% |
| Total Liabilities | $415.0M+4.7% | $403.6M+9.6% | $428.0M+21.7% | $386.6M+34.1% | $396.3M+30.7% | $368.2M+23.2% | $351.6M+9.7% | $288.2M-1.3% |
| Current Liabilities | $168.7M+2.6% | $178.8M+15.3% | $181.8M-23.8% | $149.3M+36.9% | $164.4M+26.6% | $155.0M+33.4% | $238.5M+85.5% | $109.0M-0.4% |
| Non-Current Liabilities | $246.3M+6.2% | $224.9M+5.5% | $246.2M+117.8% | $237.4M+32.4% | $231.9M+33.8% | $213.2M+16.6% | $113.0M-41.1% | $179.2M-1.9% |
| Long-Term Debt | $194.6M+3.1% | $186.2M+11.8% | $203.8M+195.8% | $195.5M+48.0% | $188.8M+48.1% | $166.6M+25.8% | $68.9M-50.5% | $132.1M+1.2% |
| Total Equity | $205.4M+28.8% | $186.6M+0.8% | $180.6M-6.6% | $170.4M-7.5% | $159.4M-9.4% | $185.2M+7.0% | $193.3M+7.0% | $184.2M+5.1% |
| Retained Earnings | $219.3M+1.3% | $218.3M-13.2% | $217.7M-20.4% | $218.4M-28.5% | $216.5M-30.2% | $251.5M-20.2% | $273.5M-14.3% | $305.7M-5.1% |
LSAK Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $16.9Mn/m | $37.6M+252.3% | -$10.9Mn/m | $8.9Mn/m | -$6.5M-214.7% | $10.7M-44.4% | -$9.2M-1672.2% | -$4.1M-222.6% |
| Depreciation & Amortization | $10.3M-4.2% | $10.5M+25.1% | $13.6M+65.0% | $12.9M+105.4% | $10.8M+73.9% | $8.4M+45.6% | $8.2M+41.5% | $6.3M+7.2% |
| Stock-Based Compensation | N/A | $1.3M-46.6% | $1.9M-26.4% | $1.9M-21.7% | N/A | $2.5M+19.5% | $2.6M+46.6% | $2.4M+35.1% |
| Capital Expenditures | $9.3M+128.0% | $3.4M+20.6% | $3.9M-37.9% | $4.0M+0.4% | $4.1M-13.1% | $2.8M-4.3% | $6.3M+187.4% | $4.0M+41.2% |
| Free Cash Flow | $7.5Mn/m | $34.2M+335.5% | -$14.8Mn/m | $4.9Mn/m | -$10.6M-1229.3% | $7.8M-51.7% | -$15.5Mn/m | -$8.1M-1534.0% |
| Investing Cash Flow | -$9.8M-199.4% | -$9.8Mn/m | -$5.7Mn/m | -$461K-263.5% | $9.9M+680.2% | -$10.0Mn/m | -$11.5M-703.0% | $282Kn/m |
| Financing Cash Flow | -$19.8Mn/m | -$3.5M-141.2% | $11.0M-70.1% | -$14.7Mn/m | -$161Kn/m | $8.5Mn/m | $36.9M+342.1% | -$15.5M-310.9% |
| Share Buybacks | $28K-97.3% | $40K+48.1% | $271K-97.8% | N/A | $1.0M-18.7% | $27K+200.0% | $12.6M+6256.6% | N/A |
Not reported in any period shown, so not listed: Dividends Paid.
LSAK Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.2%+20.3pp | 2.2%+2.0pp | 1.2%+0.9pp | 0.2%+0.3pp | -17.1%-16.8pp | 0.2%-0.3pp | 0.3%-1.3pp | 0.0%-0.2pp |
| Net Margin | 1.5%+20.3pp | 0.3%+14.2pp | 2.0%+20.5pp | -2.5%+0.5pp | -18.8%-14.6pp | -13.9%-10.9pp | -18.4%-16.5pp | -3.0%+1.2pp |
| Return on Equity | 1.4%+21.2pp | 0.3%+12.4pp | 2.0%+18.8pp | -2.5%-0.1pp | -19.8%-16.4pp | -12.1%-9.7pp | -16.8%-15.3pp | -2.5%+0.8pp |
| Return on Assets | 0.4%+5.3pp | 0.1%+3.5pp | 0.5%+5.6pp | -0.7%+0.2pp | -4.9%-3.8pp | -3.4%-2.7pp | -5.1%-4.6pp | -0.8%+0.2pp |
| Current Ratio | 1.59+0.1x | 1.54+0.2x | 1.57+0.7x | 1.61+0.1x | 1.480.0x | 1.37-0.2x | 0.89-0.7x | 1.530.0x |
| Debt-to-Equity | 0.95-0.2x | 1.00+0.1x | 1.13+0.8x | 1.15+0.4x | 1.18+0.5x | 0.90+0.1x | 0.36-0.4x | 0.720.0x |
| Liabilities-to-Equity | 2.02-0.5x | 2.16+0.2x | 2.37+0.6x | 2.27+0.7x | 2.49+0.8x | 1.99+0.3x | 1.820.0x | 1.56-0.1x |
| Asset Turnover | 0.270.0x | 0.270.0x | 0.250.0x | 0.260.0x | 0.260.0x | 0.250.0x | 0.280.0x | 0.280.0x |
| FCF Margin | 4.0%+10.3pp | 18.7%+13.8pp | -8.3%+0.5pp | 2.9%+8.2pp | -6.3%-6.9pp | 4.9%-6.9pp | -8.8%-7.7pp | -5.3%-5.7pp |
Not reported in any period shown, so not listed: Gross Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Lesaka Technologies, Inc. LSAK | FY2026 | $721.6M | $2.8M | 0.4% | $353.5M | 40/100 |
| Rackspace Technology, Inc. RXT | FY2025 | $2.7B | -$225.8M | -8.4% | $690.7M | 18/100 |
| International Money Express, Inc. IMXI | FY2025 | $607.8M | $32.7M | 5.4% | $276.7M | 61/100 |
| Palladyne AI Corp. PDYN | FY2025 | $5.2M | $10.0M | N/A | $190.9M | 35/100 |
| Allot Ltd. ALLT | FY2025 | $102.0M | $3.7M | 3.6% | $443.2M | 48/100 |
| Gorilla Technology Group Inc. GRRR | FY2025 | $101.4M | -$11.3M | -11.1% | $232.5M | 60/100 |
Where Lesaka Technologies, Inc. Ranks
Frequently Asked Questions
What is Lesaka Technologies, Inc.'s annual revenue?
Lesaka Technologies, Inc. (LSAK) reported $721.6M in total revenue for fiscal year 2026. This represents a 9.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Lesaka Technologies, Inc.'s revenue growing?
Lesaka Technologies, Inc. (LSAK) revenue grew by 9.4% year-over-year, from $659.7M to $721.6M in fiscal year 2026.
Is Lesaka Technologies, Inc. profitable?
Yes, Lesaka Technologies, Inc. (LSAK) reported a net income of $2.8M in fiscal year 2026, with a net profit margin of 0.4%.
What is Lesaka Technologies, Inc.'s EBITDA?
Lesaka Technologies, Inc. (LSAK) had EBITDA of $60.0M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Lesaka Technologies, Inc. have?
As of fiscal year 2026, Lesaka Technologies, Inc. (LSAK) had $81.4M in cash and equivalents against $194.6M in long-term debt.
What is Lesaka Technologies, Inc.'s operating margin?
Lesaka Technologies, Inc. (LSAK) had an operating margin of 1.8% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.
What is Lesaka Technologies, Inc.'s net profit margin?
Lesaka Technologies, Inc. (LSAK) had a net profit margin of 0.4% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.
What is Lesaka Technologies, Inc.'s return on equity (ROE)?
Lesaka Technologies, Inc. (LSAK) has a return on equity of 1.3% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
What is Lesaka Technologies, Inc.'s free cash flow?
Lesaka Technologies, Inc. (LSAK) generated $31.8M in free cash flow during fiscal year 2026. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Lesaka Technologies, Inc.'s operating cash flow?
Lesaka Technologies, Inc. (LSAK) generated $52.4M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.
What are Lesaka Technologies, Inc.'s total assets?
Lesaka Technologies, Inc. (LSAK) had $699.3M in total assets as of fiscal year 2026, including both current and long-term assets.
What are Lesaka Technologies, Inc.'s capital expenditures?
Lesaka Technologies, Inc. (LSAK) invested $20.6M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.
How much does Lesaka Technologies, Inc. spend on research and development?
Lesaka Technologies, Inc. (LSAK) invested $800K in research and development during fiscal year 2026.
What is Lesaka Technologies, Inc.'s current ratio?
Lesaka Technologies, Inc. (LSAK) had a current ratio of 1.59 as of fiscal year 2026, which is generally considered healthy.
What is Lesaka Technologies, Inc.'s debt-to-equity ratio?
Lesaka Technologies, Inc. (LSAK) had a debt-to-equity ratio of 0.95 as of fiscal year 2026. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
What is Lesaka Technologies, Inc.'s liabilities-to-equity ratio?
Lesaka Technologies, Inc. (LSAK) had a liabilities-to-equity ratio of 2.02 as of fiscal year 2026, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
What is Lesaka Technologies, Inc.'s return on assets (ROA)?
Lesaka Technologies, Inc. (LSAK) had a return on assets of 0.4% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
What is Lesaka Technologies, Inc.'s P/E ratio?
Lesaka Technologies, Inc. (LSAK) trades at 128x earnings, its market capitalization divided by $2.8M net income, FY2026. The market capitalization is $353.5M as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Lesaka Technologies, Inc.'s price-to-sales ratio?
Lesaka Technologies, Inc. (LSAK) trades at 0.5x sales, its market capitalization divided by $721.6M revenue, FY2026. The market capitalization is $353.5M as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Lesaka Technologies, Inc.'s Altman Z-Score?
Lesaka Technologies, Inc. (LSAK) has an Altman Z-Score of 2.21, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Lesaka Technologies, Inc.'s Piotroski F-Score?
Lesaka Technologies, Inc. (LSAK) has a Piotroski F-Score of 7 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Lesaka Technologies, Inc.'s earnings high quality?
Lesaka Technologies, Inc. (LSAK) has an earnings quality ratio of 19.02x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Lesaka Technologies, Inc. cover its interest payments?
Lesaka Technologies, Inc. (LSAK) has an interest coverage ratio of 0.69x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Lesaka Technologies, Inc.?
Lesaka Technologies, Inc. (LSAK) scores 40 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.